-
公开(公告)号：EP3110411B1
公开(公告)日：2019-11-06
申请号：EP15709428.5
申请日：2015-02-23
申请人： Pharnext
IPC分类号： A61K31/047 , A61K31/195 , A61K31/485 , A61P25/00
-
公开(公告)号：EP3348261A1
公开(公告)日：2018-07-18
申请号：EP18157222.3
申请日：2013-02-28
申请人： Pharnext
IPC分类号： A61K31/195 , A61K31/185 , A61K31/428 , A61P25/28
摘要： The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis. More specifically, the present invention relates to novel combinatorial therapies for treating amyotrophic lateral sclerosis or a related disorder.
-
公开(公告)号：EP2796132B1
公开(公告)日：2018-05-02
申请号：EP13196468.6
申请日：2012-03-01
申请人： Pharnext
IPC分类号： A61K31/137 , A61K31/138 , A61K31/185 , A61K31/195 , A61K31/42 , A61K31/64 , A61P25/16 , A61P25/28 , A61P25/00 , A61K31/145 , A61K31/164 , A61K31/44 , A61K31/445 , A61K9/20 , A61K31/428
CPC分类号： A61K31/44 , A61K9/2004 , A61K31/137 , A61K31/138 , A61K31/145 , A61K31/164 , A61K31/185 , A61K31/195 , A61K31/197 , A61K31/42 , A61K31/428 , A61K31/445 , A61K31/64 , A61K45/06 , A61K2300/00
摘要： The present invention relates to combinations and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid ² toxicity. More specifically, the present invention relates to novel combinatorial therapies of Multiple Sclerosis, Alzheimer's disease, Alzheimer's disease related disorder, Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or alcohol withdrawal, or spinal cord injury, based on Baclofen and Acamprosate combination.
-
公开(公告)号：EP2819664B1
公开(公告)日：2017-05-31
申请号：EP13706548.8
申请日：2013-02-28
申请人： Pharnext
IPC分类号： A61K31/138 , A61P25/00 , A61K31/137 , A61K31/185 , A61K31/195 , A61K31/42 , A61K31/44 , A61P29/00
CPC分类号： A61K31/185 , A61K31/137 , A61K31/138 , A61K31/197 , A61K31/428 , A61K31/44 , A61K2300/00
摘要： The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis. More specifically, the present invention relates to novel combinatorial therapies for treating amyotrophic lateral sclerosis or a related disorder.
-
5.发明授权NEW THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF ANGIOGENESIS 有权新的治疗方法用于治疗阿尔茨海默病及相关疾病按调制血管生成
公开(公告)号：EP2282778B1
公开(公告)日：2017-03-08
申请号：EP09738185.9
申请日：2009-04-29
申请人： Pharnext
发明人： COHEN, Daniel , CHUMAKOV, Ilya , NABIROCHKIN, Serguei , GUERASSIMENKO, Oxana , GRAUDENS, Esther
IPC分类号： A61K31/155 , A61K31/195 , A61K31/37 , A61K31/42 , A61K31/4365 , A61K31/55 , A61K31/64 , A61P25/28
CPC分类号： A61K31/55 , A61K31/155 , A61K31/195 , A61K31/37 , A61K31/42 , A61K31/4365 , A61K31/64 , A61K45/06 , A61K2300/00
-
公开(公告)号：EP2823817A1
公开(公告)日：2015-01-14
申请号：EP14176796.2
申请日：2010-05-28
申请人： Pharnext
IPC分类号： A61K31/192 , A61K31/197 , A61K31/4164 , A61K31/4178 , A61K31/436 , A61K31/485 , A61K31/575 , A61K31/7004 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/24 , A61P25/28 , A61K45/06
CPC分类号： A61K31/485 , A61K9/0053 , A61K31/047 , A61K31/192 , A61K31/195 , A61K31/197 , A61K31/4164 , A61K31/4178 , A61K31/436 , A61K31/439 , A61K31/555 , A61K31/567 , A61K31/575 , A61K31/7004 , A61K45/06 , A61K2300/00
摘要： The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders.
-
公开(公告)号：EP2819664A1
公开(公告)日：2015-01-07
申请号：EP13706548.8
申请日：2013-02-28
申请人： Pharnext
IPC分类号： A61K31/138 , A61P25/00 , A61K31/137 , A61K31/185 , A61K31/195 , A61K31/42 , A61K31/44 , A61P29/00
CPC分类号： A61K31/185 , A61K31/137 , A61K31/138 , A61K31/197 , A61K31/428 , A61K31/44 , A61K2300/00
摘要： The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis. More specifically, the present invention relates to novel combinatorial therapies for treating amyotrophic lateral sclerosis or a related disorder.
-
公开(公告)号：EP2437742B1
公开(公告)日：2014-08-06
申请号：EP10724399.0
申请日：2010-05-28
申请人： Pharnext
IPC分类号： A61K31/192 , A61K31/197 , A61K31/4164 , A61K31/4178 , A61K31/436 , A61K31/485 , A61K31/575 , A61K31/7004 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/24 , A61P25/28 , A61K45/06
CPC分类号： A61K31/485 , A61K9/0053 , A61K31/047 , A61K31/192 , A61K31/195 , A61K31/197 , A61K31/4164 , A61K31/4178 , A61K31/436 , A61K31/439 , A61K31/555 , A61K31/567 , A61K31/575 , A61K31/7004 , A61K45/06 , A61K2300/00
-
9.发明公开Combinations of nootropic agents for treating cognitive dysfunctions 审中-公开Kombinierungen aus Nootropikagenten zur Behandlung von kognitiven Dysfunktionen
公开(公告)号：EP2705841A1
公开(公告)日：2014-03-12
申请号：EP12306062.6
申请日：2012-09-05
申请人： Pharnext
IPC分类号： A61K31/135 , A61K31/137 , A61K31/185 , A61K31/195 , A61K31/44 , A61K31/635 , A61P25/00 , A61P25/16 , A61P25/18 , A61P25/24 , A61P25/36 , A61P39/02 , A61P43/00
CPC分类号： A61K31/44 , A61K31/135 , A61K31/137 , A61K31/138 , A61K31/16 , A61K31/185 , A61K31/195 , A61K31/197 , A61K31/42 , A61K31/635 , A61K45/06
摘要： The invention relates to compositions and methods for improving memory and related functions as alertness, attention, concentration, learning, and language processing. More particularly, the invention relates to compositions comprising at least two drugs selected from cinacalcet, baclofen, acamprosate, mexiletine, sulfisoxazole and torasemide useful to enhance memory and related functions in healthy subjects or subjects suffering from conditions or disorders having a negative impact on their memory.
摘要翻译： 本发明涉及将记忆和相关功能作为警觉性，注意力，集中力，学习和语言处理的组合物和方法。 更具体地说，本发明涉及包含至少两种选自西那卡塞，巴氯芬，阿坎酸盐，美西律，磺胺异恶唑和托拉塞米的药物的组合物，其用于增强健康受试者或患有其记忆负面影响的病症或障碍的受试者的记忆和相关功能 。
-
公开(公告)号：EP2609916A1
公开(公告)日：2013-07-03
申请号：EP12196650.1
申请日：2008-11-28
申请人： Pharnext
IPC分类号： A61K31/197 , A61K9/20 , A61K31/7004 , A61K31/485 , A61P25/28
CPC分类号： A61K31/485 , A61K9/0095 , A61K9/08 , A61K9/4866 , A61K31/047 , A61K31/197 , A61K31/7004
摘要： The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders. More particularly, the invention relates to combined therapies for treating said disease by affecting PMP22 expression in a subject.
摘要翻译： 本发明涉及用于治疗Charcot-Marie-Tooth疾病和相关病症的组合物和方法。 更具体地说，本发明涉及通过影响受试者中的PMP22表达来治疗所述疾病的组合疗法。
-
-
-
-
-
-
-
-
-
搜索结果
92 条记录 (耗时 0.038 秒)
